A detailed history of Massmutual Trust CO Fsb transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 6 shares of PRTA stock, worth $106. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 27 77.78%
Holding current value
$106
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$16.73 - $24.79 $351 - $520
-21 Reduced 77.78%
6 $0
Q2 2024

Jul 02, 2024

BUY
$19.54 - $26.15 $527 - $706
27 New
27 $0
Q4 2023

Jan 03, 2024

BUY
$32.31 - $52.32 $2,003 - $3,243
62 New
62 $2,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $831M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.